wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34407893-638692B9-E84A-4D55-8D12-23484638326B
Q34407893-638692B9-E84A-4D55-8D12-23484638326B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34407893-638692B9-E84A-4D55-8D12-23484638326B
Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus
P2860
Q34407893-638692B9-E84A-4D55-8D12-23484638326B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34407893-638692B9-E84A-4D55-8D12-23484638326B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
34cca956b7ba718965cf29667436c08a802bdc86
P2860
Pharmacological profile of ipragliflozin (ASP1941), a novel selective SGLT2 inhibitor, in vitro and in vivo.